# Care.Trials SOLVE Token Projection

--

*Disclaimer: Information in this article is strictly for informational purposes. SOLVE is a utility token and discussion is strictly around utility. This is not financial advice.*

In recent years, the healthcare industry has struggled with the way clinical trials are conducted. The cost is too high and the participation is low but thanks to Care.Trials, Solve.Care can finally fix clinical trials and accelerate medical advances around the world. This article explores the transformative impact of SOLVE tokens on the economics of clinical trials, focusing on key statistics and projections that showcase the potential of SOLVE.Care to reshape the landscape of patient enrollment costs.

# User Participation and Costs

Each clinical trial has three phases, the participant count progressively increases: On average, Phase 1 requires 100 participants, Phase 2 requires 250, and Phase 3 requires 4,000 participants. The average cost to enroll one participant decreases across these phases, with Phase 1 costing $19,000 per participant, Phase 2 at $13,000, and Phase 3 at $6,000.

Before Care.Trials, the total cost for those who conduct clinical trials across the three phases amounted to a staggering $29,150,000, averaging $6,701 per participant. However, the introduction of Care.Trials aims to cut enrollment costs in half, resulting in a total per trial cost of $14,575,000. Extrapolating this data reveals that each trial would require approximately 565,907,554 SOLVE tokens, translating to an average of 130,000 SOLVE tokens utilized per successful participant.

Let’s say that again for those that missed it! **One clinical trial completed via Care.Trials users would utilize 565M SOLVE tokens!**

The tokenomics becomes even more apparent when considering future projections.

# Projections for Increased Participation

To illustrate the expansive real world demand of SOLVE on large-scale clinical trials, let’s consider the scenario of trials with 100, 1,000, and 10,000 participants. With 100 participants, the SOLVE token requirement would be 13M SOLVE; with 1,000 participants, it increases to 130M SOLVE, and **with 10,000 participants, a remarkable 1.3B SOLVE tokens would be utilized**. These projections demonstrate the scalability of SOLVE.Care in accommodating trials of varying sizes.

# Future Trends and Expansion

Considering the ever-evolving nature of the healthcare industry, it is noteworthy that the average cost of enrolling one patient is expected to increase by at least **16% over the next 10 years**. In addition to this, the number of clinical trials being completed over the next 10 years is expected to increase 248% over the previous 10 years! Solve.Care’s solution not only addresses the current challenges in clinical trial economics but also positions itself as a resilient and future-proof platform that can adapt to emerging trends.

# Conclusion

Care.Trials integration into the clinical trial ecosystem has the potential to revolutionize the economics of patient enrollment. By significantly reducing costs and introducing a blockchain-based token system, SOLVE.Care not only enhances efficiency in trial management but also opens doors to more extensive and inclusive research. As the number of trials utilizing SOLVE.Care continues to grow, the platform stands as a beacon for the future of decentralized and cost-effective healthcare solutions.